Prognostic Score and Benefit from Abiraterone in First-line Metastatic, Castration-resistant Prostate Cancer.
Lorente D, Llacer C, Lozano R, de Velasco G, Romero-Laorden N, Rodrigo M, Sánchez-Iglesias Á, di Capua C, Castro E, Ferrer C, Sánchez-Hernández A, Olmos D.
Lorente D, et al. Among authors: di capua c.
Eur Urol. 2021 Nov;80(5):641-649. doi: 10.1016/j.eururo.2021.07.014. Epub 2021 Aug 6.
Eur Urol. 2021.
PMID: 34373138